Phantom criteria for qualification of brain FDG and amyloid PET across different cameras

BACKGROUND: While fluorodeoxyglucose (FDG) and amyloid PET is valuable for patient management, research, and clinical trial of therapeutics on Alzheimer’s disease, the specific details of the PET scanning method including the PET camera model type influence the image quality, which may further affec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikari, Yasuhiko, Akamatsu, Go, Nishio, Tomoyuki, Ishii, Kenji, Ito, Kengo, Iwatsubo, Takeshi, Senda, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052249/
https://www.ncbi.nlm.nih.gov/pubmed/27709546
http://dx.doi.org/10.1186/s40658-016-0159-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052249/
https://www.ncbi.nlm.nih.gov/pubmed/27709546
http://dx.doi.org/10.1186/s40658-016-0159-y

Ejemplares similares